English | 繁體

Search in the results

UM

Browse/Search Results:  1-3 of 3 Help

Selected(0)Clear Items/Page:    Sort:
Blockade of TNFR2 signaling enhances the immunotherapeutic effect of CpG ODN in a mouse model of colon cancer Journal article
Nie, Yingjie, He, Jiang, Shirota, Hidekazu, Trivett, Anna L., Yang, De, Klinman, Dennis M., Oppenheim, Joost J., Chen, Xin. Blockade of TNFR2 signaling enhances the immunotherapeutic effect of CpG ODN in a mouse model of colon cancer[J]. SCIENCE SIGNALING, 2018, 11(511).
Authors:  Nie, Yingjie;  He, Jiang;  Shirota, Hidekazu;  Trivett, Anna L.;  Yang, De; et al.
Favorite | TC[WOS]:53 TC[Scopus]:56  IF:6.7/7.2 | Submit date：2018/10/30
Targeting TNFR2, an immune checkpoint stimulator and oncoprotein, is a promising treatment for cancer Journal article
Chen, Xin, Oppenheim, Joost J.. Targeting TNFR2, an immune checkpoint stimulator and oncoprotein, is a promising treatment for cancer[J]. SCIENCE SIGNALING, 2017, 10(462).
Authors:  Chen, Xin;  Oppenheim, Joost J.
Favorite | TC[WOS]:60 TC[Scopus]:59  IF:6.7/7.2 | Submit date：2018/10/30
The NF-κB subunit RelB controls p100 processing by competing with the kinases NIK and IKK1 for binding to p100 Journal article
Fusco A.J., Mazumder A., Wang V.Y.-F., Tao Z., Ware C., Ghosh G.. The NF-κB subunit RelB controls p100 processing by competing with the kinases NIK and IKK1 for binding to p100[J]. Science Signaling, 2016, 9(447).
Authors:  Fusco A.J.;  Mazumder A.;  Wang V.Y.-F.;  Tao Z.;  Ware C.; et al.
Favorite | TC[WOS]:19 TC[Scopus]:19 | Submit date：2019/01/15